
Helping You Assess, Understand and Minimise Clinical Risk.
With a wealth of clinical, investigatory and IT knowledge and expertise, TMLEP offers a range of services for individuals and organisations in the healthcare sector, specifically focused on assessing, understanding and minimising clinical risk.

Our Services
TMLEP is a pioneering independent clinical practice, providing clinical investigations, analytics and healthtech solutions to healthcare providers, insurers, lawyers, and regulators across the globe with the clear aim of ensuring clinical liability can be accurately assessed and healthcare standards and patient safety are improved.
With offices in both the United Kingdom and Australia, TMLEP is able to assist clients across the globe.
Please feel free to browse our website to understand more about our practice and the services we offer. If you have any questions, please do not hesitate to get in touch to discuss your requirements.
Evidence
Where expert evidence is required for clinical negligence matters, you can take comfort knowing you are obtaining one of the most robust and reliable expert opinions available.
Investigations
We assist healthcare providers to independently investigate concerns in relation to the provision of healthcare, providing independent serious incident reports and complaints investigations.
Healthtech
Our healthcare technology and data solutions provide the capability to drive real change in the delivery of healthcare and analysis of clinical risk.
Clinical Learning


TMLEP COO Speaks on AI at Medico-Legal Congress Sydney
“Innovation isn’t about replacing humans; it’s about empowering them!”
Read Article 29 Apr 2024
TMLEP Unveils Cutting-Edge Medico-Legal Technologies at the 33rd Annual Medico Legal Congress in Sydney
TMLEP, a renowned UK-based healthcare and legal technology provider, is proud to announce its sponsorship of the 33rd Annual Medico Legal Congress in Sydney on 19-20 March 2024, where it will be unveiling its new technologies for the Australian medico-legal market.
Read Article 17 Jan 2024